Dr. Dopchie Cathérine, oncoloog: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Dr. Dopchie Cathérine, oncoloog
Largest movements
- Cash +€35,913
up €35,913 (+16.9%), from €212,323 to €248,236
mainly Other debts (+€101,925) and Net result for the year (+€91,935)
- Profit (loss) carried forward -€158,927
no longer reported in 2025 (was €158,927)
- Other debts +€101,925
up €101,925 (+970%), from €10,503 to €112,428
- Reserves +€89,935
up €89,935 (+313%), from €28,722 to €118,657
of which Distributable reserves: +€91,935
- Gross operating margin +€132,988
up €132,988, from -€3,401 to €129,587
- Taxes +€36,459
up €36,459 (+7,489%), from €487 to €36,946
- Financial income -€8,940
down €8,940 (-97.1%), from €9,204 to €263
of which Non-recurring financial income: -€8,000
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €219,077 | €254,369 | +€35,291 | +16.1% |
| Current assets | 29/58 | €219,077 | €254,369 | +€35,291 | +16.1% |
| Amounts receivable within one year | 40/41 | €6,754 | €6,133 | -€621 | -9.2% |
| Other amounts receivable | 41 | €6,754 | €6,133 | -€621 | -9.2% |
| Cash at bank and in hand | 54/58 | €212,323 | €248,236 | +€35,913 | +16.9% |
| Total equity and liabilities | 10/49 | €219,077 | €254,369 | +€35,291 | +16.1% |
| Equity | 10/15 | €207,648 | €138,657 | -€68,992 | -33.2% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Reserves | 13 | €28,722 | €118,657 | +€89,935 | +313% |
| Non-distributable reserves | 130/1 | €2,000 | - | -€2,000 | |
| Reserves not available under the articles | 1311 | €2,000 | - | -€2,000 | |
| Distributable reserves | 133 | €26,722 | €118,657 | +€91,935 | +344% |
| Profit (loss) carried forward | 14 | €158,927 | - | -€158,927 | |
| Amounts payable | 17/49 | €11,429 | €115,712 | +€104,283 | +912% |
| Amounts payable within one year | 42/48 | €11,363 | €113,145 | +€101,782 | +896% |
| Trade debts | 44 | €427 | €717 | +€290 | +67.9% |
| Suppliers | 440/4 | €427 | €717 | +€290 | +67.9% |
| Taxes, remuneration and social security | 45 | €433 | - | -€433 | |
| Taxes | 450/3 | €433 | - | -€433 | |
| Other amounts payable | 47/48 | €10,503 | €112,428 | +€101,925 | +970% |
| Accrued charges and deferred income | 492/3 | €66 | €2,567 | +€2,501 | +3,807% |
| Other operating charges | 640/8 | €823 | €919 | +€96 | +11.6% |
| Gross operating margin | 9900 | -€3,401 | €129,587 | +€132,988 | |
| Operating profit (loss) | 9901 | -€4,224 | €128,669 | +€132,893 | |
| Financial income | 75/76B | €9,204 | €263 | -€8,940 | -97.1% |
| Recurring financial income | 75 | €1,204 | €263 | -€940 | -78.1% |
| Non-recurring financial income | 76B | €8,000 | - | -€8,000 | |
| Financial charges | 65/66B | €45 | €51 | +€6 | +13.3% |
| Recurring financial charges | 65 | €45 | €51 | +€6 | +13.3% |
| Profit (loss) for the period before taxes | 9903 | €4,934 | €128,881 | +€123,946 | +2,512% |
| Income taxes | 67/77 | €487 | €36,946 | +€36,459 | +7,489% |
| Profit (loss) for the period | 9904 | €4,448 | €91,935 | +€87,487 | +1,967% |
| Profit (loss) for the period to be appropriated | 9905 | €4,448 | €91,935 | +€87,487 | +1,967% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 November 2026 via checked.be.